Conditions: Pain
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 500
Healthy volunteers: no

Brief summary:
The purpose of this study is to collect disease burden of OA and the effectiveness and patient satisfaction of treatment by Etoricoxib in the normal practice setting.

Detailed description:

Arms:
arm 1: Etoricoxib

Interventions: intervention 1: etoricoxib
Intervention descriptions: intervention 1: etoricoxib 60 mg QD for 4 weeks.

Protocol document: